欧美日韩亚洲国产天堂区_日韩精品无码熟人妻视频一本大道_青青草精品在线观看_香蕉视频色的直播内容_欧美亚洲综合另类色多多_久久天天躁狠狠躁夜夜Av_亚洲中文字幕乱码在线播放_三级综合在线观看精品_国产艳妇蜜臀AV_精品同人动漫cg福利图片

Intermediates

Commercial

Indication Product Name CAS No. Structure

Losartan

2-Butyl-4-chloro-5-formylimidazole;BCFI 83857-96-9
Telmisartan 2-n-propyl-4-methyl-6-(1-methylbenzimidazole-2-ylbenzimidazole);BIM 152628-02-9
Rivaroxaban 4-(4-aminophenyl)morpholin-3-one 438056-69-0
5-Chlorothiophene-2-carbonyl chloride 42518-98-9  
5-Chlorothiophene-2-carboxylic Acid 24065-33-6  
(S)-N-Glycidylphthalimide 161596-47-0  
2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione 446292-08-6  
(S)-4-(4-(5-(AMinoMethyl)-2-oxooxazolidin-3-yl)phenyl)Morpholin-3-one hydrochloride 898543-06-1  

Dabigatran Etexilate Mesilate 
 
 
N-(4-Cyano-Phenyl)-Glycine 42288-26-6
4-Methylamino-3-nitro benzoic acid 41263-74-5
N-Ethyl 3-(pyridin-2-ylamino)propanoate 103041-38-9
3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate 212322-56-0
Benazepril  3-Bromo-2,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one 86499-96-9
 Sildenafil 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide hydrochloride 247584-10-7
Arotinolol 5-(2-sulfanylidene-3H-1,3-thiazol-4-yl)thiophene-2-carboxamide 52560-89-1
Dronedarone
(2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone 141645-16-1
(2-butyl-5-nitrobenzofuran-3-yl)(4-(3-(dibutylaMino)propoxy)phenyl)Methanone 141645-23-0
Baricitinib 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile 1187595-85-2
7-((2-(triMethylsilyl)ethoxy)Methyl)-4-chloro-7H-pyrrolo[2,3-d]pyriMidine 941685-26-3
4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl-7H-pyrrolo[2,3-d]pyrimidine 941685-27-4
[4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate 1146629-77-7
 Celecoxib 4'-Methylacetophenone 122-00-9
4-Hydrazinobenzene-1-sulfonamide hydrochloride 17852-52-7
4,4,4-Trifluoro-1-(p-tolyl)-1,3-butanedione 720-94-5
Isavuconazole 2-Bromo-4'-cyanoacetophenone 20099-89-2
Deucravacitinib Methyl 4,6-dichloropyridazine-3-carboxylate 372118-01-9
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline 1609394-10-6
Salbutamol alpha-[(benzyl-tert-butylamino)methyl]-m-xylene-4,alpha,alpha'-triol 24085-03-8
 Olaparib 3-Bromo-4-fluorobenzaldehyde 77771-02-9
3-Cyano-4-fluorobenzaldehyde 218301-22-5
2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile 763114-25-6
 Netupitant 6-(4-Methylpiperazin-1-yl)-4-(2-methylphenyl)nicotinamide 342417-01-0
2-(3,5-bis(trifluoroMethyl)phenyl)-2-Methyl propanoic acid 289686-70-0
N-Methyl-4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinamine Oxalic acid 290297-25-5
Pazopanib

N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMine 444731-75-3
2,3-dimethyl-2H-indazol-6-amine hydrochloride 635702-60-2
 Oxcarbazepine

10-Methoxy Iminostilbene (10-MISB) 4698-11-7
Iminodibenzyl(IDB) 494-19-9
Carbamazepine
Dibenz[b,f]azepine-5-carbonyl chloride(ISBCC) 33948-22-0  
Iminostilbene(ISB) 256-96-2  
Baclofen 3-(4-Chlorophenyl)glutaric acid 35271-74-0
 Tapentadol Hydrochloride 3’-Methoxypropiophenone;3-MPP 37951-49-8
 Tramadol hydrochloride 3-Bromoanisole;MBA 2398-37-0
 Vonoprazan Fumarate
 
5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde 881674-56-2
yridine-3-sulfonyl chloride 16133-25-8

Under R&D

Indication Product Name CAS No. Structure

Rimegepan

(6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one 1190363-46-2
2-Oxo-1-(4-piperidinyl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine dihydrochloride 781649-84-1
1-(1-(1H-imidazole-1-carbonyl)piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one 1373116-06-3
Upadacitinib (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester 1428243-26-8
Carbamic acid,N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl este 1869118-24-0  

Ubrogepant 
 
 
(3S,5S,6R)-3-amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one hydrochloride 1375470-88-4
(3'S)-1',2',5,7-Tetrahydro-2'-oxospiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxylic acid 1375541-21-1
  • Tel:0546-5057288
  • E-mail:kjb@harwaypharma.com
  • Back to top